Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Total 13F shares
-
69,478,160
-
Share change
-
+259,006
-
Total reported value
-
$5,331,874,119
-
Put/Call ratio
-
56%
-
Price per share
-
$76.73
-
Number of holders
-
302
-
Value change
-
+$80,806,659
-
Number of buys
-
142
-
Number of sells
-
131
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q4 2020
As of 31 Dec 2020,
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,478,160 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Johnson & Johnson Innovation - JJDC, Inc., Invesco Ltd., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CREDIT SUISSE AG/, and FMR LLC.
This page lists
302
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.